Hydroxyurea‐induced stomatocytes in a patient presenting with polycythemia vera

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|90|6|573-573

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.6, 2015-06, pp. : 573-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HYDROXYUREA‐INDUCED CUTANEOUS ULCERATION IN OLDER PATIENTS

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 48, Iss. 2, 2000-02 ,pp. : 232-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

By  

CANCER, Vol. 120, Iss. 4, 2014-02 ,pp. : 513-520

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of Polycythemia Vera after Chemotherapy-Induced Remission of Acute Myeloid Leukemia: A Case Report

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-03 ,pp. : 52-53

Karger

Access to resources Recommend Favorite

Polycythemia Vera Management and Challenges in the Community Health Setting

By  

Oncology, Vol. 92, Iss. 4, 2017-01 ,pp. : 179-189

Karger

Access to resources Recommend Favorite

Development of JAK2V617F-Positive Polycythemia Vera after Chemotherapy-Induced Remission of Primary Central Nervous System Diffuse Large B Cell Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-05 ,pp. : 142-145

Karger

Access to resources Recommend Favorite